Compare CRIS & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRIS | TPCS |
|---|---|---|
| Founded | 2000 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 45.1M |
| IPO Year | 2000 | 2008 |
| Metric | CRIS | TPCS |
|---|---|---|
| Price | $4.00 | $4.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 60.4K | 23.0K |
| Earning Date | 05-07-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | 41.38 |
| EPS | N/A | ★ N/A |
| Revenue | $9,898,000.00 | ★ $31,644,000.00 |
| Revenue This Year | $27.10 | N/A |
| Revenue Next Year | $67.74 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.18 | $2.88 |
| 52 Week High | $6.74 | $6.25 |
| Indicator | CRIS | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 55.57 | 53.46 |
| Support Level | $4.36 | $4.41 |
| Resistance Level | $5.55 | $4.71 |
| Average True Range (ATR) | 0.51 | 0.16 |
| MACD | -0.19 | -0.02 |
| Stochastic Oscillator | 24.68 | 58.97 |
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.